Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$732
|
$688B |
14.0x |
35.8x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$152
|
$378B |
4.2x |
11.9x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$175
|
$371B |
6.5x |
14.4x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 420
|
$280B |
6.3x |
12.9x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 246
|
$242B |
3.5x |
8.8x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£100
|
$224B |
4.0x |
11.9x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$79
|
$223B |
3.5x |
8.2x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 86
|
$210B |
4.1x |
10.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$286
|
$202B |
5.9x |
10.3x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$167B |
2.6x |
6.9x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$104
|
$144B |
5.0x |
12.1x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$144B |
3.0x |
14.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€90
|
$128B |
2.7x |
9.1x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$484
|
$120B |
10.6x |
53.8x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£13
|
$84.7B |
2.1x |
6.0x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 233
|
$81.6B |
5.3x |
15.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$149
|
$71.4B |
7.7x |
18.0x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3933
|
$69.9B |
2.3x |
9.0x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6286
|
$62.1B |
7.9x |
16.1x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€115
|
$62.0B |
2.7x |
9.4x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€20
|
$56.3B |
1.1x |
5.3x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 524
|
$46.6B |
6.0x |
20.6x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1688
|
$44.9B |
7.3x |
25.4x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 48
|
$39.1B |
9.9x |
39.2x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3105
|
$34.0B |
2.7x |
14.9x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 50
|
$30.7B |
1.9x |
6.5x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 161100
|
$24.6B |
9.4x |
30.3x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$22.2B |
1.5x |
5.0x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6724
|
$22.2B |
1.4x |
6.2x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 6
|
$21.7B |
2.2x |
6.5x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$115
|
$21.1B |
2.2x |
6.3x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1270
|
$19.8B |
1.6x |
7.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$32
|
$19.7B |
6.9x |
7.4x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 32
|
$19.0B |
1.8x |
9.2x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€7
|
$15.0B |
1.9x |
7.7x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 23
|
$14.1B |
8.1x |
21.7x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 374500
|
$13.5B |
158.1x |
334.1x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 244
|
$13.3B |
20.1x |
35.8x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1463
|
$12.8B |
4.0x |
15.4x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€47
|
$12.6B |
4.9x |
13.1x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3129
|
$12.5B |
9.3x |
28.5x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.2B |
2.2x |
16.0x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$11.1B |
1.7x |
5.7x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2351
|
$10.8B |
7.5x |
28.6x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 22
|
$10.7B |
1.9x |
10.5x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1109
|
$10.6B |
2.8x |
10.3x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1969
|
$10.4B |
4.0x |
17.0x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 254
|
$10.2B |
3.9x |
10.6x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 868
|
$9.8B |
3.7x |
12.5x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 48
|
$9.3B |
6.8x |
435.2x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 21
|
$9.2B |
2.9x |
7.5x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 82
|
$9.0B |
25.7x |
-383.3x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 37
|
$8.6B |
1.4x |
12.9x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 302
|
$8.4B |
31.7x |
-318.6x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2158
|
$8.4B |
2.8x |
6.8x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$91
|
$8.4B |
3.4x |
12.2x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$60
|
$8.3B |
7.8x |
12.4x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€95
|
$8.1B |
2.2x |
6.0x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1225
|
$7.9B |
2.4x |
7.1x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 4
|
$7.6B |
1.9x |
8.0x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1082
|
$7.4B |
2.0x |
9.5x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€48
|
$7.4B |
4.4x |
12.9x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$7.3B |
0.2x |
3.4x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 29579
|
$7.1B |
9.4x |
36.3x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 44
|
$7.1B |
1.8x |
9.7x |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 183
|
$7.0B |
16.2x |
21.7x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 5
|
$6.7B |
1.7x |
6.9x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4887
|
$6.4B |
4.2x |
21.3x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£18
|
$6.3B |
2.0x |
7.5x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3550
|
$6.2B |
1.2x |
9.8x |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 317
|
$6.0B |
3.4x |
17.1x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$5.8B |
4.6x |
13.7x |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 22
|
$5.8B |
6.7x |
13.5x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2085
|
$5.6B |
1.7x |
7.3x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 27
|
$5.6B |
N/A |
N/A |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 109547
|
$5.6B |
3.9x |
59.9x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€108
|
$5.2B |
N/A |
N/A |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 150
|
$5.2B |
2.1x |
7.8x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2747
|
$5.2B |
11.8x |
38.8x |
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10240
|
$5.0B |
2.1x |
5.7x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€168
|
$5.0B |
2.4x |
8.8x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1627
|
$5.0B |
1.5x |
6.5x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 98
|
$4.8B |
N/A |
N/A |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 34
|
$4.7B |
7.7x |
26.6x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.7B |
1.6x |
7.3x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$19
|
$4.6B |
10.3x |
25.2x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1378
|
$4.5B |
2.9x |
15.9x |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 495
|
$4.2B |
12.3x |
54.3x |
Amoytop Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 77
|
$4.2B |
9.9x |
26.3x |
Yili Chuannig Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 12
|
$3.9B |
N/A |
N/A |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 47
|
$3.9B |
5.4x |
18.5x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 17
|
$3.8B |
6.2x |
14.5x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$3.8B |
7.1x |
25.9x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$3.8B |
2.5x |
9.4x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$22
|
$3.8B |
N/A |
N/A |
Zelgen Biopharmaceuticals
|
China |
Drug Development & Therapeutics,
Biopharmaceuticals
|
CNY 106
|
$3.7B |
34.0x |
N/A |
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 12
|
$3.5B |
2.7x |
8.1x |
Hypera
|
Brazil |
Biopharmaceuticals,
Drug Development & Therapeutics
|
BRL 19
|
$3.5B |
2.6x |
9.1x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 27
|
$3.4B |
11.3x |
-28.0x |
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 42
|
$3.2B |
12.3x |
-23.4x |